{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:17:04Z","timestamp":1788412624004,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":38,"publisher":"Springer US","isbn-type":[{"value":"9781071614594","type":"print"},{"value":"9781071614600","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-1460-0_9","type":"book-chapter","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T18:22:26Z","timestamp":1625682146000},"page":"231-245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Measuring Efflux and Permeability in Mycobacteria"],"prefix":"10.1007","author":[{"given":"Liliana","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"A\u00ednsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Viveiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41579-018-0048-6","volume":"16","author":"D Du","year":"2018","unstructured":"Du D, Wang-Kan X, Neuberger A et al (2018) Multidrug efflux pumps: structure, function and regulation. Nat Rev Microbiol 16:523\u2013539","journal-title":"Nat Rev Microbiol"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.coph.2011.07.001","volume":"11","author":"JG Pasipanodya","year":"2011","unstructured":"Pasipanodya JG, Gumbo T (2011) A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs. Curr Opin Pharmacol 11:457\u2013463","journal-title":"Curr Opin Pharmacol"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/jac\/dkz370","volume":"74","author":"LJV Piddock","year":"2019","unstructured":"Piddock LJV (2019) The 2019 Garrod lecture: MDR efflux in gram-negative bacteria-how understanding resistance led to a new tool for drug discovery. J Antimicrob Chemother 74:3128\u20133134","journal-title":"J Antimicrob Chemother"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1574-6976.2005.00002.x","volume":"30","author":"E De Rossi","year":"2006","unstructured":"De Rossi E, A\u00ednsa JA, Riccardi G (2006) Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol Rev 30:36\u201352","journal-title":"FEMS Microbiol Rev"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.drudis.2017.01.002","volume":"22","author":"L Rodrigues","year":"2017","unstructured":"Rodrigues L, Parish T, Balganesh M et al (2017) Antituberculosis drugs: reducing efflux=increasing activity. Drug Discov Today 22:592\u2013599","journal-title":"Drug Discov Today"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2011.02.022","volume":"145","author":"KN Adams","year":"2011","unstructured":"Adams KN, Takaki K, Connolly LE et al (2011) Drug tolerance in replicating myco- bacteria mediated by a macrophage-induced efflux mechanism. Cell 145:39\u201353","journal-title":"Cell"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1128\/AAC.05946-11","volume":"56","author":"S Ram\u00f3n-Garc\u00eda","year":"2012","unstructured":"Ram\u00f3n-Garc\u00eda S, Mick V, Dainese E et al (2012) Functional and genetic characterization of the tap efflux pump in Mycobacterium bovis BCG. Antimicrob Agents Chemother 56:2074\u20132083","journal-title":"Antimicrob Agents Chemother"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1128\/AAC.00550-09","volume":"53","author":"S Ram\u00f3n-Garc\u00eda","year":"2009","unstructured":"Ram\u00f3n-Garc\u00eda S, Mart\u00edn C, Thompson CJ et al (2009) Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. Antimicrob Agents Chemother 53:3675\u20133682","journal-title":"Antimicrob Agents Chemother"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nm.3458","volume":"20","author":"RE Lee","year":"2014","unstructured":"Lee RE, Hurdle JG, Liu J et al (2014) Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux. Nat Med 20:152\u2013158","journal-title":"Nat Med"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1128\/AAC.06003-11","volume":"56","author":"M Balganesh","year":"2012","unstructured":"Balganesh M, Dinesh N, Sharma S et al (2012) Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates. Antimicrob Agents Chemother 56:2643\u20132651","journal-title":"Antimicrob Agents Chemother"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1128\/AAC.00610-10","volume":"54","author":"M Balganesh","year":"2010","unstructured":"Balganesh M, Kuruppath S, Marcel N et al (2010) Rv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discovery. Antimicrob Agents Chemother 54:5167\u20135172","journal-title":"Antimicrob Agents Chemother"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1586\/eri.12.89","volume":"10","author":"M Viveiros","year":"2012","unstructured":"Viveiros M, Martins M, Rodrigues L et al (2012) Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs. Expert Rev Anti-Infect Ther 10:983\u2013998","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/jac\/dkv316","volume":"71","author":"CM Pule","year":"2016","unstructured":"Pule CM, Sampson SL, Warren RM et al (2016) Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy. J Antimicrob Chemother 71:17\u201326","journal-title":"J Antimicrob Chemother"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/1389201043376878","volume":"5","author":"KO Greulich","year":"2004","unstructured":"Greulich KO (2004) Single molecule techniques for biomedicine and pharmacology. Curr Pharm Biotechnol 5:243\u2013259","journal-title":"Curr Pharm Biotechnol"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/cyto.990170405","volume":"17","author":"MW Jernaes","year":"1994","unstructured":"Jernaes MW, Steen HB (1994) Staining of Escherichia coli for flow cytometry: influx and efflux of ethidium bromide. Cytometry 17:302\u2013309","journal-title":"Cytometry"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.bcp.2005.12.008","volume":"71","author":"O Lomovskaya","year":"2006","unstructured":"Lomovskaya O, Bostian KA (2006) Practical applications and feasibility of efflux pump inhibitors in the clinic \u2013 a vision for applied use. Biochem Pharmacol 71:910\u2013918","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"9_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00840-16","volume":"7","author":"JM Blair","year":"2016","unstructured":"Blair JM, Piddock LJ (2016) How to measure export via bacterial multidrug resistance efflux pumps. mBio 7(4):e00840\u201316","journal-title":"mBio"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ijantimicag.2007.12.015","volume":"31","author":"M Viveiros","year":"2008","unstructured":"Viveiros M, Martins A, Paix\u00e3o L et al (2008) Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. Int J Antimicrob Agents 31:458\u2013462","journal-title":"Int J Antimicrob Agents"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/jac\/dki436","volume":"57","author":"S Ram\u00f3n-Garc\u00eda","year":"2006","unstructured":"Ram\u00f3n-Garc\u00eda S, Mart\u00edn C, A\u00ednsa JA et al (2006) Characterization of tetracycline resistance mediated by the efflux pump tap from Mycobacterium fortuitum. J Antimicrob Chemother 57:252\u2013259","journal-title":"J Antimicrob Chemother"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"760","DOI":"10.2174\/138945008785747734","volume":"9","author":"M Viveiros","year":"2008","unstructured":"Viveiros M, Martins M, Couto I et al (2008) New methods for the identification of efflux mediated MDR bacteria, genetic assessment of regulators and efflux pump constituents, characterization of efflux systems and screening for inhibitors of efflux pumps. Curr Drug Targets 9:760\u2013778","journal-title":"Curr Drug Targets"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1754-1611-3-18","volume":"3","author":"L Paix\u00e3o","year":"2009","unstructured":"Paix\u00e3o L, Rodrigues L, Couto I et al (2009) Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli. J Biol Eng 3:18","journal-title":"J Biol Eng"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2180-11-35","volume":"11","author":"L Rodrigues","year":"2011","unstructured":"Rodrigues L, Ramos J, Couto I et al (2011) Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance. BMC Microbiol 11:35","journal-title":"BMC Microbiol"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1128\/AAC.01482-12","volume":"57","author":"L Rodrigues","year":"2013","unstructured":"Rodrigues L, Villellas C, Bailo R et al (2013) Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 57:751\u2013757","journal-title":"Antimicrob Agents Chemother"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3389\/fmicb.2017.00711","volume":"8","author":"D Machado","year":"2017","unstructured":"Machado D, Coelho TS, Perdig\u00e3o J et al (2017) Interplay between mutations and efflux in drug resistant clinical isolates of Mycobacterium tuberculosis. Front Microbiol 8:711","journal-title":"Front Microbiol"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.meegid.2011.08.009","volume":"12","author":"L Rodrigues","year":"2012","unstructured":"Rodrigues L, Machado D, Couto I et al (2012) Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex. Infect Genet Evol 12:695\u2013700","journal-title":"Infect Genet Evol"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"e00228","DOI":"10.1128\/JB.00228-19","volume":"201","author":"ER Ballister","year":"2019","unstructured":"Ballister ER, Samanovic MI, Darwin KH (2019) Mycobacterium tuberculosis Rv2700 contributes to cell envelope integrity and virulence. J Bacteriol 201:e00228\u2013e00219","journal-title":"J Bacteriol"},{"key":"9_CR27","first-page":"e01334","volume":"61","author":"W Xu","year":"2017","unstructured":"Xu W, DeJesus MA, R\u00fccker N et al (2017) Chemical genetic interaction profiling reveals determinants of intrinsic antibiotic resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 61:e01334\u2013e01317","journal-title":"Antimicrob Agents Chemother"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"e00653","DOI":"10.1128\/IAI.00653-16","volume":"85","author":"EA Williams","year":"2017","unstructured":"Williams EA, Mba Medie F, Bosserman RE et al (2017) A nonsense mutation in Mycobacterium marinum that is suppressible by a novel mechanism. Infect Immun 85:e00653\u2013e00616","journal-title":"Infect Immun"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"e00359","DOI":"10.1128\/AAC.00359-18","volume":"62","author":"C Aguilar-P\u00e9rez","year":"2018","unstructured":"Aguilar-P\u00e9rez C, Gracia B, Rodrigues L et al (2018) Synergy between circular bacteriocin AS-48 and ethambutol against Mycobacterium tuberculosis. Antimicrob Agents Chemother 62:e00359\u2013e00318","journal-title":"Antimicrob Agents Chemother"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.tube.2018.08.004","volume":"112","author":"G Mori","year":"2018","unstructured":"Mori G, Orena BS, Franch C et al (2018) The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase. Tuberculosis (Edinb) 112:98\u2013109","journal-title":"Tuberculosis (Edinb)"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1021\/acsinfecdis.6b00075","volume":"2","author":"SA Bonnett","year":"2016","unstructured":"Bonnett SA, Ollinger J, Chandrasekera S et al (2016) A target-based whole cell screen approach to identify potential inhibitors of Mycobacterium tuberculosis signal peptidase. ACS Infect Dis 2:893\u2013902","journal-title":"ACS Infect Dis"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2217\/fmb-2017-0232","volume":"13","author":"SS Nakamura de Vasconcelos","year":"2018","unstructured":"Nakamura de Vasconcelos SS, Caleffi-Ferracioli KR, Hegeto LA et al (2018) Carvacrol activity & morphological changes in Mycobacterium tuberculosis. Future Microbiol 13:877\u2013888","journal-title":"Future Microbiol"},{"key":"9_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149326","volume":"11","author":"D Machado","year":"2016","unstructured":"Machado D, Pires D, Perdig\u00e3o J et al (2016) Ion channel blockers as antimicrobial agents, efflux inhibitors, and enhancers of macrophage killing activity against drug resistant Mycobacterium tuberculosis. PLoS One 11:e0149326","journal-title":"PLoS One"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","volume":"46","author":"JC Palomino","year":"2002","unstructured":"Palomino JC, Martin A, Camacho M et al (2002) Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 46:2720\u20132722","journal-title":"Antimicrob Agents Chemother"},{"key":"9_CR35","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1089\/adt.2016.752","volume":"14","author":"SS Costa","year":"2016","unstructured":"Costa SS, Lopes E, Azzali E et al (2016) An experimental model for the rapid screening of compounds with potential use against mycobacteria. Assay Drug Dev Technol 14:524\u2013534","journal-title":"Assay Drug Dev Technol"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1590\/S1517-83822013000100042","volume":"44","author":"K Pe\u00f1uelas-Urquides","year":"2013","unstructured":"Pe\u00f1uelas-Urquides K, Villarreal-Trevi\u00f1o L, Silva-Ram\u00edrez B et al (2013) Measuring of Mycobacterium tuberculosis growth. A correlation of the optical measurements with colony forming units. Braz J Microbiol 44:287\u2013289","journal-title":"Braz J Microbiol"},{"key":"9_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e02263","volume":"5","author":"MD Rakhmawatie","year":"2019","unstructured":"Rakhmawatie MD, Wibawa T, Lisdiyanti P et al (2019) Evaluation of crystal violet decolorization assay and resazurin microplate assay for antimycobacterial screening. Heliyon 5:e02263","journal-title":"Heliyon"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.tube.2012.07.003","volume":"92","author":"SG Franzblau","year":"2012","unstructured":"Franzblau SG, DeGroote MA, Cho SH et al (2012) Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis. Tuberculosis (Edinb) 92:453\u2013488","journal-title":"Tuberculosis (Edinb)"}],"container-title":["Methods in Molecular Biology","Mycobacteria Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1460-0_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T01:39:19Z","timestamp":1662169159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1460-0_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9781071614594","9781071614600"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1460-0_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"8 July 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}